|Rapid Review Complete
|For the relief of pain and inflammation in osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.
|Rapid review commissioned
|Rapid review completed
|Rapid review outcome
|Following a resubmission of the rapid review a full pharmacoeconomic evaluation is recommended at the submitted price.
The HSE has approved reimbursement following confidential price negotiations Nov 2017.